- Home
- Publications
- Publication Search
- Publication Details
Title
Metal-Based PSMA Radioligands
Authors
Keywords
-
Journal
MOLECULES
Volume 22, Issue 4, Pages 523
Publisher
MDPI AG
Online
2017-03-24
DOI
10.3390/molecules22040523
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preclinical Comparative Study of 68Ga-Labeled DOTA, NOTA, and HBED-CC Chelated Radiotracers for Targeting PSMA
- (2016) Sangeeta Ray Banerjee et al. BIOCONJUGATE CHEMISTRY
- Development of 99mTc-labeled asymmetric urea derivatives that target prostate-specific membrane antigen for single-photon emission computed tomography imaging
- (2016) Hiroyuki Kimura et al. BIOORGANIC & MEDICINAL CHEMISTRY
- 64Cu-PSMA-617 PET/CT Imaging of Prostate Adenocarcinoma: First In-Human Studies
- (2016) Bernhard Grubmüller et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- 68Ga-Labeled Anti–Prostate-Specific Membrane Antigen Peptide as Marker for Androgen Deprivation Therapy Response in Prostate Cancer
- (2016) Carl Diedrich Schlenkhoff et al. CLINICAL NUCLEAR MEDICINE
- Widespread Metastatic Prostate Carcinoma Shown by 68Ga-PSMA PET/CT
- (2016) Cigdem Soydal et al. CLINICAL NUCLEAR MEDICINE
- 68Ga-PSMA PET/CT Imaging and 153Sm-EDTMP Bone Pain Palliation Therapy
- (2016) Arun Sasikumar et al. CLINICAL NUCLEAR MEDICINE
- Radioligand Therapy With 177Lu-PSMA-617 as A Novel Therapeutic Option in Patients With Metastatic Castration Resistant Prostate Cancer
- (2016) Kambiz Rahbar et al. CLINICAL NUCLEAR MEDICINE
- 68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT
- (2016) Christina Bluemel et al. CLINICAL NUCLEAR MEDICINE
- 68Ga-PSMA-11 dynamic PET/CT imaging in biochemical relapse of prostate cancer
- (2016) C. Sachpekidis et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Intra-individual comparison of 68Ga-PSMA-11-PET/CT and multi-parametric MR for imaging of primary prostate cancer
- (2016) F. L. Giesel et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 68Ga-PSMA I&T PET/CT for assessment of prostate cancer: evaluation of image quality after forced diuresis and delayed imaging
- (2016) Thorsten Derlin et al. EUROPEAN RADIOLOGY
- 68Ga-PSMA Positron Emission Tomography/Computed Tomography Provides Accurate Staging of Lymph Node Regions Prior to Lymph Node Dissection in Patients with Prostate Cancer
- (2016) Annika Herlemann et al. EUROPEAN UROLOGY
- 551 Feasibility of 111In-PSMA-guided surgery for treatment of nodal prostate cancer relapse
- (2016) K. Schaal et al. EUROPEAN UROLOGY SUPPLEMENTS
- Linker Modification Strategies To Control the Prostate-Specific Membrane Antigen (PSMA)-Targeting and Pharmacokinetic Properties of DOTA-Conjugated PSMA Inhibitors
- (2016) Martina Benešová et al. JOURNAL OF MEDICINAL CHEMISTRY
- First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake
- (2016) N. Pandit-Taskar et al. JOURNAL OF NUCLEAR MEDICINE
- Response and Tolerability of a Single Dose of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: A Multicenter Retrospective Analysis
- (2016) K. Rahbar et al. JOURNAL OF NUCLEAR MEDICINE
- PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617
- (2016) C. Kratochwil et al. JOURNAL OF NUCLEAR MEDICINE
- Preclinical Evaluation and First Patient Application of 99m Tc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer
- (2016) Stephanie Robu et al. JOURNAL OF NUCLEAR MEDICINE
- 177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy
- (2016) R. P. Baum et al. JOURNAL OF NUCLEAR MEDICINE
- Systemic Radioligand Therapy with 177Lu Labeled Prostate Specific Membrane Antigen Ligand for Imaging and Therapy in Patients with Metastatic Castration Resistant Prostate Cancer
- (2016) Matthias M. Heck et al. JOURNAL OF UROLOGY
- The Role of Positron Emission Tomography With 68Gallium (Ga)-Labeled Prostate-specific Membrane Antigen (PSMA) in the Management of Patients With Organ-confined and Locally Advanced Prostate Cancer Prior to Radical Treatment and After Radical Prostatectomy
- (2016) Bhavan Prasad Rai et al. UROLOGY
- Therapeutic response and side effects of repeated radioligand therapy with 177Lu-PSMA-DKFZ-617 of castrate-resistant metastatic prostate cancer
- (2016) Hojjat Ahmadzadehfar et al. Oncotarget
- Synthesis and evaluation of constrained phosphoramidate inhibitors of prostate-specific membrane antigen
- (2015) Corinne R. Ley et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Metastatic Prostate Carcinoma Presenting as a Superscan on 68Ga-PSMA PET/CT
- (2015) Ismaheel Lawal et al. CLINICAL NUCLEAR MEDICINE
- PSMA PET/CT with Glu-urea-Lys-(Ahx)-[68Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer
- (2015) Frederik L. Giesel et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 68Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients
- (2015) Florian Sterzing et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Comparison of hybrid 68Ga-PSMA PET/MRI and 68Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer
- (2015) Martin T. Freitag et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Extent of disease in recurrent prostate cancer determined by [68Ga]PSMA-HBED-CC PET/CT in relation to PSA levels, PSA doubling time and Gleason score
- (2015) Frederik A. Verburg et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
- (2015) Francesco Ceci et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prostate-specific Membrane Antigen–radioguided Surgery for Metastatic Lymph Nodes in Prostate Cancer
- (2015) Tobias Maurer et al. EUROPEAN UROLOGY
- Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane Antigen
- (2015) A. P. Kiess et al. JOURNAL OF NUCLEAR MEDICINE
- 18F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer
- (2015) S. P. Rowe et al. JOURNAL OF NUCLEAR MEDICINE
- The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions
- (2015) A. Afshar-Oromieh et al. JOURNAL OF NUCLEAR MEDICINE
- A Novel 111In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer
- (2015) K. L. S. Chatalic et al. JOURNAL OF NUCLEAR MEDICINE
- Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy
- (2015) M. Eiber et al. JOURNAL OF NUCLEAR MEDICINE
- Pilot Comparison of 68Ga-RM2 PET and 68Ga-PSMA-11 PET in Patients with Biochemically Recurrent Prostate Cancer
- (2015) R. Minamimoto et al. JOURNAL OF NUCLEAR MEDICINE
- Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy
- (2015) J. J. Morigi et al. JOURNAL OF NUCLEAR MEDICINE
- Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer
- (2015) M. Bene ova et al. JOURNAL OF NUCLEAR MEDICINE
- 68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies
- (2015) M. Weineisen et al. JOURNAL OF NUCLEAR MEDICINE
- Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate Cancer
- (2015) Jessie R. Nedrow et al. MOLECULAR IMAGING AND BIOLOGY
- Radiofluorination of PSMA-HBED via Al18F2+ Chelation and Biological Evaluations In Vitro
- (2015) Noeen Malik et al. MOLECULAR IMAGING AND BIOLOGY
- Comparison of [18F]DCFPyL and [68Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer
- (2015) Markus Dietlein et al. MOLECULAR IMAGING AND BIOLOGY
- Initial Evaluation of [18F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer
- (2015) Zsolt Szabo et al. MOLECULAR IMAGING AND BIOLOGY
- Synthesis and positron emission tomography evaluation of 18F-Glu-Urea-Lys, a prostate-specific membrane antigen-based imaging agent for prostate cancer
- (2015) WEIWEI FAN et al. Oncology Letters
- PSMA Ligands for Radionuclide Imaging and Therapy of Prostate Cancer: Clinical Status
- (2015) Susanne Lütje et al. Theranostics
- [111In]PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgery
- (2015) Margret Schottelius et al. EJNMMI Research
- Early side effects and first results of radioligand therapy with 177Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study
- (2015) Hojjat Ahmadzadehfar et al. EJNMMI Research
- (R)-NODAGA-PSMA: A Versatile Precursor for Radiometal Labeling and Nuclear Imaging of PSMA-Positive Tumors
- (2015) Eleni Gourni et al. PLoS One
- Generation and characterization of nanobodies targeting PSMA for molecular imaging of prostate cancer
- (2014) Mehdi Evazalipour et al. Contrast Media & Molecular Imaging
- Preparation and evaluation of carborane-derived inhibitors of prostate specific membrane antigen (PSMA)
- (2014) Mohamed E. El-Zaria et al. DALTON TRANSACTIONS
- The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
- (2014) Ali Afshar-Oromieh et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Structural and biochemical characterization of the folyl-poly-γ-l-glutamate hydrolyzing activity of human glutamate carboxypeptidase II
- (2014) Michal Navrátil et al. FEBS Journal
- 64Cu-Labeled Inhibitors of Prostate-Specific Membrane Antigen for PET Imaging of Prostate Cancer
- (2014) Sangeeta Ray Banerjee et al. JOURNAL OF MEDICINAL CHEMISTRY
- 99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen: Pharmacokinetics and Biodistribution Studies in Healthy Subjects and Patients with Metastatic Prostate Cancer
- (2014) S. Vallabhajosula et al. JOURNAL OF NUCLEAR MEDICINE
- Noninvasive Imaging of PSMA in Prostate Tumors with 89Zr-Labeled huJ591 Engineered Antibody Fragments: The Faster Alternatives
- (2014) Nerissa Therese Viola-Villegas et al. MOLECULAR PHARMACEUTICS
- A Theranostic “SMART” Aptamer for Targeted Therapy of Prostate Cancer
- (2014) Vittorio de Franciscis MOLECULAR THERAPY
- Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy
- (2014) Hongguang Sun et al. Molecular Therapy-Nucleic Acids
- Design and preclinical evaluation of a 99mTc-labelled diabody of mAb J591 for SPECT imaging of prostate-specific membrane antigen (PSMA)
- (2014) Florian Kampmeier et al. EJNMMI Research
- Synthesis and preclinical evaluation of DOTAGA-conjugated PSMA ligands for functional imaging and endoradiotherapy of prostate cancer
- (2014) Martina Weineisen et al. EJNMMI Research
- New cross-bridged cyclam derivative CB-TE1K1P, an improved bifunctional chelator for copper radionuclides
- (2013) Dexing Zeng et al. CHEMICAL COMMUNICATIONS
- Phase II Study of Lutetium-177-Labeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Metastatic Castration-Resistant Prostate Cancer
- (2013) S. T. Tagawa et al. CLINICAL CANCER RESEARCH
- Preclinical evaluation of BAY 1075553, a novel 18F-labelled inhibitor of prostate-specific membrane antigen for PET imaging of prostate cancer
- (2013) Ralf Lesche et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
- (2013) Ali Afshar-Oromieh et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Effect of Chelators on the Pharmacokinetics of 99mTc-Labeled Imaging Agents for the Prostate-Specific Membrane Antigen (PSMA)
- (2013) Sangeeta Ray Banerjee et al. JOURNAL OF MEDICINAL CHEMISTRY
- 99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen for Molecular Imaging of Prostate Cancer
- (2013) S. M. Hillier et al. JOURNAL OF NUCLEAR MEDICINE
- A Prospective Pilot Study of 89Zr-J591/Prostate Specific Membrane Antigen Positron Emission Tomography in Men with Localized Prostate Cancer Undergoing Radical Prostatectomy
- (2013) Joseph R. Osborne et al. JOURNAL OF UROLOGY
- 68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging
- (2012) Matthias Eder et al. BIOCONJUGATE CHEMISTRY
- Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer
- (2012) C. Barinka et al. CURRENT MEDICINAL CHEMISTRY
- The Renaissance of the 68Ge/68Ga Radionuclide Generator Initiates New Developments in 68Ga Radiopharmaceutical Chemistry
- (2012) Frank Roesch et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Radiopharmaceutical development of radiolabelled peptides
- (2012) Melpomeni Fani et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
- (2012) A. Afshar-Oromieh et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with Metastatic Prostate Cancer
- (2012) S. Y. Cho et al. JOURNAL OF NUCLEAR MEDICINE
- Triazole Appending Agent (TAAG): A New Synthon for Preparing Iodine-Based Molecular Imaging and Radiotherapy Agents
- (2012) Alla Darwish et al. ACS Medicinal Chemistry Letters
- A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancer
- (2012) Martin Schäfer et al. EJNMMI Research
- Radiosynthesis of a new PSMA targeting ligand ([18F]FPy-DUPA-Pep)
- (2011) Noeen Malik et al. APPLIED RADIATION AND ISOTOPES
- Synthesis and radiolabeling of chelator–RNA aptamer bioconjugates with copper-64 for targeted molecular imaging
- (2011) William M. Rockey et al. BIOORGANIC & MEDICINAL CHEMISTRY
- 2-(3- -Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer
- (2011) Y. Chen et al. CLINICAL CANCER RESEARCH
- 123I-MIP-1072, a Small-Molecule Inhibitor of Prostate-Specific Membrane Antigen, Is Effective at Monitoring Tumor Response to Taxane Therapy
- (2011) S. M. Hillier et al. JOURNAL OF NUCLEAR MEDICINE
- Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen
- (2011) M. J. Evans et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A phosphoramidate-based prostate-specific membrane antigen-targeted SPECT agent
- (2011) Jessie R. Nedrow-Byers et al. PROSTATE
- Anti-prostate-Specific membrane antigen-based radioimmunotherapy for prostate cancer
- (2010) Scott T. Tagawa et al. CANCER
- 68Ga-Labeled Inhibitors of Prostate-Specific Membrane Antigen (PSMA) for Imaging Prostate Cancer
- (2010) Sangeeta Ray Banerjee et al. JOURNAL OF MEDICINAL CHEMISTRY
- 89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo
- (2010) J. P. Holland et al. JOURNAL OF NUCLEAR MEDICINE
- Radionuclide and hybrid imaging of recurrent prostate cancer
- (2010) Ambros J Beer et al. LANCET ONCOLOGY
- Aptamers as therapeutics
- (2010) Anthony D. Keefe et al. NATURE REVIEWS DRUG DISCOVERY
- High-resolution animal PET imaging of prostate cancer xenografts with three different 64Cu-labeled antibodies against native cell-adherent PSMA
- (2010) Karen Alt et al. PROSTATE
- Targeting cancer cells with nucleic acid aptamers
- (2010) Laura Cerchia et al. TRENDS IN BIOTECHNOLOGY
- Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure–activity relationship studies
- (2009) Haofan Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Copper-64 Radiopharmaceuticals for PET Imaging of Cancer: Advances in Preclinical and Clinical Research
- (2009) Carolyn J. Anderson et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues That Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer
- (2009) S. M. Hillier et al. CANCER RESEARCH
- Dose-response effect of Gelofusine on renal uptake and retention of radiolabelled octreotate in rats with CA20948 tumours
- (2009) Marleen Melis et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Assessment of an 18F-Labeled Phosphoramidate Peptidomimetic as a New Prostate-Specific Membrane Antigen-Targeted Imaging Agent for Prostate Cancer
- (2009) S. E. Lapi et al. JOURNAL OF NUCLEAR MEDICINE
- Recombinant Anti-CD20 Antibody Fragments for Small-Animal PET Imaging of B-Cell Lymphomas
- (2009) T. Olafsen et al. JOURNAL OF NUCLEAR MEDICINE
- Molecular imaging targeting peptide receptors
- (2009) Margret Schottelius et al. METHODS
- Biorecognition and Subcellular Trafficking of HPMA Copolymer−Anti-PSMA Antibody Conjugates by Prostate Cancer Cells
- (2009) Jihua Liu et al. MOLECULAR PHARMACEUTICS
- Design, Synthesis, and Preclinical Evaluation of Prostate-Specific Membrane Antigen Targeted99mTc-Radioimaging Agents
- (2009) Sumith A. Kularatne et al. MOLECULAR PHARMACEUTICS
- Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors
- (2009) Justin P Dassie et al. NATURE BIOTECHNOLOGY
- Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancer
- (2009) Philipp Wolf et al. PROSTATE
- Pseudoirreversible Inhibition of Prostate-Specific Membrane Antigen by Phosphoramidate Peptidomimetics†
- (2008) Tiancheng Liu et al. BIOCHEMISTRY
- Humanized Radioiodinated Minibody For Imaging of Prostate Stem Cell Antigen-Expressing Tumors
- (2008) J. V. Leyton et al. CLINICAL CANCER RESEARCH
- N-[N-[(S)-1,3-Dicarboxypropyl]Carbamoyl]-4-[18F]Fluorobenzyl-L-Cysteine, [18F]DCFBC: A New Imaging Probe for Prostate Cancer
- (2008) R. C. Mease et al. CLINICAL CANCER RESEARCH
- Synthesis and Evaluation of Technetium-99m- and Rhenium-Labeled Inhibitors of the Prostate-Specific Membrane Antigen (PSMA)
- (2008) Sangeeta R. Banerjee et al. JOURNAL OF MEDICINAL CHEMISTRY
- Radiohalogenated Prostate-Specific Membrane Antigen (PSMA)-Based Ureas as Imaging Agents for Prostate Cancer
- (2008) Ying Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Series of Halogenated Heterodimeric Inhibitors of Prostate Specific Membrane Antigen (PSMA) as Radiolabeled Probes for Targeting Prostate Cancer
- (2008) K. P. Maresca et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cell-Surface labeling and internalization by a fluorescent inhibitor of prostate-specific membrane antigen
- (2008) Tiancheng Liu et al. PROSTATE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More